Switching Between JAK Inhibiters in RA Save
Dr. Janet Pope discusses abstract 0274 presented at ACR22 Convergence in Philadelphia, PA. Abstract 0274: Real-world Utilisation and Switching Between Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in the Australian OPAL Dataset
If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.